Product
ZM-02-L
1 clinical trial
1 indication
Indication
Retinitis PigmentosaClinical trial
Prospective, Dose-Escalating, Investigator Initiated Trial to Evaluate the Safety and Efficacy of ZM-02 in Retinitis PigmentosaStatus: Not yet recruiting, Estimated PCD: 2027-12-25